Search for: "Janssen Research "
Results 1 - 20
of 200
Sorted by Relevance
|
Sort by Date
5 Sep 2008, 8:28 am
Prosthetics Research Assocs., Inc. v. [read post]
22 Dec 2015, 6:39 am
., a synthetic biology firm, now has a research collaboration agreement with another company to work on treatments for diabetes and other health problems. [read post]
6 Apr 2015, 6:27 pm
In other Topamax news, new research indicates that Topiramate (its generic name) can exacerbate or trigger eating disorder symptoms in certain adolescents. [read post]
1 Nov 2015, 9:57 pm
Par Pharmaceutical Inc. et al. 1:15-cv-00679; filed August 3, 2015 in the District Court of Delaware • Plaintiffs: Janssen Biotech Inc.; Janssen Oncology Inc.; Janssen Research & Development LLC • Defendants: Amneal Pharmaceuticals LLC; Amneal Pharmaceuticals of New York LLC; Par Pharmaceutical Inc.; Par Pharmaceutical Companies Inc. [read post]
14 May 2014, 11:30 am
Maarten Janssen (National Research University Higher School of Economics), Alexei Parakhonyak (National Research University Higher School of Economics), and Anastasia Parakhonyak (Toulouse School of Economics) analyze Non-reservation price equilibria and Consumer search. discuss Non-reservation price equilibria and Consumer search. [read post]
13 Oct 2020, 12:00 am
Switching Costs, Brand Premia and Behavioral Pricing in the Pharmaceutical Market Aljoscha Janssen Singapore Management University; Research Institute of Industrial Economics (IFN) Date Written: May 20, 2020 Abstract This article examines the market power of branded prescription drugs faced with... [read post]
18 Sep 2020, 12:00 am
Price Dynamics of Swedish Pharmaceuticals Aljoscha Janssen Singapore Management University; Research Institute of Industrial Economics (IFN) Abstract This paper investigates price patterns of off-patent pharmaceuticals in Sweden. [read post]
18 Sep 2020, 8:45 am
Switching Costs, Brand Premia and Behavioral Pricing in the Pharmaceutical Market Aljoscha Janssen Singapore Management University; Research Institute of Industrial Economics (IFN) Abstract This article examines the market power of branded prescription drugs faced with generic competition. [read post]
4 Jan 2019, 5:00 am
Klaus Peter Gugler, Vienna University of Economics and Business; European Corporate Governance Institute (ECGI), Sven Heim, Centre for European Economic Research (ZEW), Maarten Janssen, University of Vienna - Faculty of Business, Economics, and Statistics, and Mario Liebensteiner, Vienna University of... [read post]
3 Aug 2012, 12:27 pm
The deal is an expansion of an existing partnership between Evotec and the Harvard lab of Douglas Melton known as the CureBeta research and development program, created [...] [read post]
14 Jan 2015, 4:34 pm
While YODA members may reach out to Janssen researchers with questions, the final decision on data sharing will be made by YODA. [read post]
30 Dec 2016, 6:28 am
Janssen Research and Development was formerly known as Johnson and Johnson Pharmaceuticals Research and is still a wholly owned subsidiary of the pharmaceutical giant. [read post]
14 Jan 2014, 9:30 am
However, in keeping with Janssen Inc v Teva (supra), I find that there is also a requirement to provide evidence that the research is relevant. [read post]
18 Nov 2020, 11:19 am
Last year, however, a research study confirmed that prolonged use of Elmiron can cause serious damage to the retinas in the eyes. [read post]
5 Sep 2012, 12:25 pm
This post was written by Erin Janssen. [read post]
5 Sep 2012, 12:25 pm
This post was written by Erin Janssen. [read post]
11 May 2012, 6:01 am
Janssen. [read post]
19 Jan 2018, 12:28 pm
Johnson & Johnson and it’s Janssen subsidiary are exposed to allegations that the companies failed to adequately research the potential side effects of Invokana, and failed to warn about severe side effects from its blockbuster line of new diabetic drugs. [read post]
19 Jan 2018, 12:28 pm
Johnson & Johnson and it’s Janssen subsidiary are exposed to allegations that the companies failed to adequately research the potential side effects of Invokana, and failed to warn about severe side effects from its blockbuster line of new diabetic drugs. [read post]
13 Feb 2012, 3:04 pm
Researchers at J&J’s Janssen unit knew as early as 1999that a study found Risperdal caused diabetes at a higher ratethan a competing drug and failed to hand over the results toregulators probing links between the disease and anti-psychoticmedicines.Source: http://www.bloomberg.com/news/2012-02-02/j-j-hid-risperdal-studies-to-boost-drug-sales-lawyer-says-at-n-j-trial.html [read post]
